Otar Yener, Gülçin
Loading...
Profile URL
Name Variants
Job Title
Email Address
gyener@pau.edu.tr
Main Affiliation
14.02. Internal Medicine
Status
Former Staff
Website
ORCID ID
Scopus Author ID
Turkish CoHE Profile ID
Google Scholar ID
WoS Researcher ID
No research topics data found.
Sustainable Development Goals
1NO POVERTY
0
Research Products
2ZERO HUNGER
0
Research Products
3GOOD HEALTH AND WELL-BEING
2
Research Products
4QUALITY EDUCATION
0
Research Products
5GENDER EQUALITY
0
Research Products
6CLEAN WATER AND SANITATION
0
Research Products
7AFFORDABLE AND CLEAN ENERGY
0
Research Products
8DECENT WORK AND ECONOMIC GROWTH
0
Research Products
9INDUSTRY, INNOVATION AND INFRASTRUCTURE
0
Research Products
10REDUCED INEQUALITIES
0
Research Products
11SUSTAINABLE CITIES AND COMMUNITIES
0
Research Products
12RESPONSIBLE CONSUMPTION AND PRODUCTION
0
Research Products
13CLIMATE ACTION
0
Research Products
14LIFE BELOW WATER
0
Research Products
15LIFE ON LAND
0
Research Products
16PEACE, JUSTICE AND STRONG INSTITUTIONS
0
Research Products
17PARTNERSHIPS FOR THE GOALS
0
Research Products
This researcher does not have a Scopus ID.
This researcher does not have a WoS ID.
No records found in other affiliations.
Scholarly Output
10
Articles
7
Views / Downloads
624/213
Supervised MSc Theses
0
Supervised PhD Theses
0
WoS Citation Count
28
Scopus Citation Count
32
Patents
0
Projects
0
WoS Citations per Publication
2.80
Scopus Citations per Publication
3.20
Open Access Source
7
Supervised Theses
0
| Journal | Count |
|---|---|
| ANNALS OF THE RHEUMATIC DISEASES | 3 |
| Rheumatology International | 2 |
| Lupus | 1 |
| Turk Pediatri Arsivi | 1 |
| World Journal of Clinical Cases | 1 |
Current Page: 1 / 2
Scopus Quartile Distribution
Competency Cloud
10 results
Scholarly Output Search Results
Now showing 1 - 10 of 10
Conference Object Exploring the relation between pain and activity and participation based on icf in children and adolescents with juvenil idiopatik artrit: a pilot study(BMJ PUBLISHING GROUP, 2020-06) Kabul, E. Gur; Calik, B. Basakci; Akar, B.; Bali, M.; Tekin, Z. Ekici; Yener, G. Otar; Yuksel, S.Abstract Not AvailableConference Object THE FREQUENCY OF JOINT HYPERMOBILITY IN TURKISH SCHOOLCHILDREN: EFFECTS(BMJ PUBLISHING GROUP, 2019-06) Tekin, Zahide Ekici; Yener, Gulcin Otar; Calik, Bilge Basakci; Yuksel, SelcukAbstract Not AvailableConference Object UVEITIS IN PEDIATRIC RHEUMATOLOGY: TERTIARY CENTER EXPERIENCE IN TURKEY(BMJ PUBLISHING GROUP, 2019-06) Tekin, Zahide Ekici; Yener, Gulcin Otar; Cetin, Ebru Nevin; Akbulut, Selen; Yuksel, SelcukAbstract Not AvailableReview Citation - WoS: 9Citation - Scopus: 11Eosinophilic granulomatosis with polyangiitis without respiratory symptoms or asthma in an adolescent: case report and literature review(Springer Verlag, 2017-11-30) Yener, Gulcin Otar; Tekin, Zahide Ekici; Demirkan, Nese Calli; Yuksel, SelcukEosinophilic granulomatosis with polyangiitis (EGPA), also known as Churg–Strauss syndrome, is a systemic necrotizing vasculitis of the small and medium vessels. It is primarily associated with respiratory conditions such as asthma and sinusitis as well as eosinophilia, neuropathy, pulmonary infiltrates, and vasculitis. EGPA is extremely rare in the pediatric age group, and respiratory system disorders are usually predominant in EGPA patients. A 14-year-old boy presented with rash and severe extremity pain. He had eosinophilia, and electroneuromyography demonstrated sensorimotor polyneuropathy. His skin biopsy revealed necrotizing eosinophilic vasculitis and eosinophilic panniculitis. Although he had no respiratory symptoms or history of asthma, prominent pulmonary involvement was evident on thoracic MRI. After treatment, his complaints of pain improved but mild neuropathy persisted. After 4 years of follow-up, he had minimal hypoesthesia in his right hand but had not experienced any relapses. This case highlights the fact that in cases suspected of EGPA, even without respiratory symptoms or asthma, detailed imaging should be performed for a definitive diagnosis. In addition, mild neurological findings may persist despite treatment in EGPA. The relevant literature on EGPA, with specific reference to pediatric cases, is reviewed. © 2017, Springer-Verlag GmbH Germany, part of Springer Nature.Article Citation - WoS: 2Citation - Scopus: 3Psoriatic fasciitis in a pediatric patient: A case report(Baishideng Publishing Group Co, 2019-01-06) Yener, Gülçin Otar; Tekin, Zahide Ekici; Yüksel, SelçukBACKGROUND Diffuse fasciitis with psoriatic arthritis on magnetic resonance imaging (MRI) has not been previously described in childhood. Here we present the first case report of a pediatric patient developing fasciitis, beyond plantar fasciitis, with psoriatic arthritis. CASE SUMMARY An 11-year-old female was admitted with the complaints of psoriatic rash on the body associated with severe pain in the lower extremities and arthritis in the right knee. Psoriasis was confirmed by skin biopsy, she diagnosed with juvenile psoriatic arthritis. Diagnostic tests did not indicate any pathology except MRI. MRI of the femur and tibia revealed that high-signal inflammatory changes in the subdermal fascia. These findings led to a diagnosis of psoriatic fasciitis. Methotrexate was given for 3 mo but the patient showed no response to therapy; therefore, etanercept was added. However, there was no response to treatment. Etanercept was switched to adalimumab at the sixth month of therapy. Clinical improvement started with therapy of adalimumab within one month. Fasciitis finding in MRI disappeared at seventh months on adalimumab therapy. She has no complaint for two years with adalimumab. CONCLUSION The most effective imaging method is MRI and adalimumab may be the best choice of treatment for psoriatic fasciitis. © The Author(s) 2019.Review Citation - WoS: 8Citation - Scopus: 9Acquired angioedema in juvenile systemic lupus erythematosus: case-based review(Springer Verlag, 2018-06-27) Tekin, Zahide Ekici; Yener, Gulcin Otar; Yuksel, SelcukAn acquired form of angioedema that is clinically similar but scarcer than the hereditary form may be caused, even more rarely, by the presence of an underlying autoimmune disease. We report a previously healthy 16-year-old girl with an acquired angioedema as a rare and initial presentation of systemic lupus erythematosus. The patient had no previous angioedema attack and no family history. She did not have any chronic diseases and did not use any medicine regularly. The patient was diagnosed with systemic lupus erythematosus with the presence of polyarthralgia, angioedema, leucopenia, and positivity of immunologic criteria. Her edema resolved with high-dose methylprednisolone and hydroxychloroquine slowly. In conclusion, new-onset angioedema in adolescent girls should be investigated to evaluate autoimmunity and the possibility of systemic lupus erythematosus. The related literature on acquired angioedema associated with systemic lupus erythematosus is also reviewed. © 2018, Springer-Verlag GmbH Germany, part of Springer Nature.Article Longitudinal Assessment of Disease Burden in Juvenile Systemic Lupus Erythematosus: A Multicenter Study of Activity and Damage Scores(Sage Publications Ltd, 2025-09-29) Aydin, Duygu; Tunce, Eray; Kavrul Kayaalp, Gulsah; Tuzen, Hande Ilgaz; Alkan, Dorukcan; Oguz, Gorkem; Karali, Yasin; Sönmez, Hafize EmineIntroduction Juvenile Systemic Lupus Erythematosus (jSLE) is a rare pediatric rheumatic disease characterized by systemic inflammation that can lead to organ damage. Compared to adults, it often has a more severe course in children. Both disease activity and treatments may result in temporary or permanent damage.Objectives To evaluate risk factors associated with damage occurrence in patients with jSLE.Methods This multicenter, retrospective study included patients with jSLE followed for at least 12 months. Low-dose corticosteroid therapy was defined as prednisolone 0.01-0.03 mg/kg/day (max 7.5 mg/day). The annual cumulative steroid dose was calculated by dividing the total steroid intake by 365.25 times the number of follow-up years. Collected data included SLEDAI and SDI scores at initial and final visits, laboratory parameters, and flare characteristics.Results A total of 158 patients (86.7% female) from 17 centers were included. Median age at diagnosis was 13.8 years, with a median follow-up of 35 months. Organ damage was present in 14 patients at diagnosis and in 23 at final visit. Damage types included proteinuria, cognitive dysfunction (each 3.2%), and others such as cataracts, erosive arthritis, avascular necrosis, optic atrophy, and vertebral collapse. Patients with damage had significantly higher SLEDAI scores at both time points, delayed transition to low-dose steroids, and a lower rate of achieving Lupus Low Disease Activity State (LLDAS) (p = .006).Conclusion Persistent disease activity and delayed control are major contributors to organ damage in jSLE. Early and sustained disease suppression is critical to prevent long-term complications.Article Citation - WoS: 9Citation - Scopus: 9Juvenile idiopathic arthritis in a center in the western anatolia region in turkey(Kare Publishing, 2019) Yener, Gulcin Otar; Tekin, Zahide Ekici; Girisgen, Ilknur; Cetin, Ebru Nevin; Akdag, Beyza; Yuksel, SelcukAim: To demonstrate the demographic data, subgroup distributions, responses to treatment and outcomes of long-term follow-up in patients who were followed up and treated in our clinics with a diagnosis of juvenile idiopathic arthritis, and to compare these data with national and international data. Material and Methods: The files of 116 patients who had been diagnosed as having juvenile idiopathic arthritis, were initiated on treatment and presented for regular follow-up visits between January 2012 and January 2018, were examined. Their demographic findings, treatments, active/inactive disease states (on-medication and off-medication) and treatment response states were evaluated. Results: According to the International League of Associations for Rheumatology criteria, the subtypes were specified as enthesitis-related arthritis (n=38), oligoarticular (n=37), rheumatoid factor (-) polyarticular (n=17), systemic (n=15), rheumatoid factor (+) polyarticular (n=5), and psoriatic juvenile idiopathic arthritis (n=4). In total, the female/male ratio was found to be 1.5. The mean delay time between the first complaint and the diagnosis was found to be 5.7±5.2 months. The patients with systemic type were diagnosed at the earliest, while the patients with polyarticular and enthesitis-related subtypes were diagnosed at the latest. Thirty-two percent of the patients were treated with methotrexate alone, and 38% were given additional biologic drugs. In both treatment groups, the time to achieve inactive disease was the shortest in the oligoarticular group and the longest in the enthesitis-related arthritis group. In the study period, 38 patients were in remission off-medication (the highest rate (53.3%) was observed in the systemic group) and 71 patients were in remission on-medication (the highest rate (70.2%) was observed in the oligoarticular group). Remission was obtained in 94% of the patients. Conclusion: Enthesitis which is the remarkable finding of enthesitis-related arthritis, should not be overlooked in routine physical examination. Awareness of enthesitis can contribute to the prevention of diagnostic delay in children with enthesitis-related arthritis. ©Copyright 2020 by Turkish Pediatric Association-Available online at www.turkpediatriarsivi.com.Article İntrakardiak trombüs gelişen Behçet hastalıklı bir çocuk hasta(2017) Yuksel, Selcuk; Yener, Gulcin Otar; Tekin, Zahide Ekici; Gürses, DolunayÇocukluk çağında çok nadir görülen Behçet hastalığı kronik sistemik inflamatuar bir hastalıktır. Behçet hastalığıher boyuttaki arter ve venleri tutabilen yegâne vaskülit olup yoğun inflamasyona ikincil olarak venlerde trombozayatkınlık gelişirken,arterlerde anevrizma, tromboz ya da darlık oluşabilmektedir. Behçet hastalarında çok dahanadir olarak intrakardiak tromboz görülebilmektedir. Behçet hastalığının bu nadir komplikasyonları,morbiditeve mortaliteyi belirlemede çok önemli olduğu için bir an önce tanınıp tedavi edilmelidir. Bu yazı ile intrakardiaktromboz gelişmiş Behçet hastalığı tanılı çocuğa tanı ve tedavi amaçlı nasıl yaklaştığımız hakkında bilgi verilmiştir.Article The validity and reliability of the Juvenile Arthritis Functional Assessment Report (JAFAR) in children/adolescents with Juvenile Idiopathic Arthritis: The Turkish version study(Izzet Kara, 2023-09-22) Bali, Merve; Kabul, Elif Gur; Calik, Bilge Basakci; Yener, Gulcin Otar; Tekin, Zahide Ekici; Yuksel, SelcukThe aim of the study was to describe the validity and reliability of the Turkish version of Juvenile Arthritis Functional Assessment Report (JAFAR) in children/adolescents with Juvenile Idiopathic Arthritis (JIA). Sixty-nine children/adolescents with JIA were included in the study. JAFAR(TR)-Child and Parent forms were applied to the patients with JIA and to their parents for test retest at one-week intervals, the patients did not receive additional treatment and his/her pharmacological treatment did not change for that week. Test-retest reliability was evaluated by intraclass correlation coefficient (ICC), and internal consistency reliability of multi-item subscales was evaluated by calculating Cronbach's alpha coefficient. Correlations between JAFAR(TR)-Child and Parent with the Pediatric Quality of Life Inventory 3.0. Module Arthritis (PedsQL), the Childhood Health Assessment Questionnaire (CHAQ), and the Juvenile Arthritis Disease Activity Score (JADAS) were evaluated to determine construct validity. The ICC value for the test/retest reliability of JAFAR(TR)-Child was 0.963 and of JAFAR(TR)-Parent was 0.576. JAFAR(TR)-Child total score had low to moderate correlations with PedsQL Child (r=-0.34; p=0.004), CHAQ (r=0.40; p=0.001), and JADAS total score (r=0.42; p=0.000). JAFAR(TR)-Parent total score had moderate to high correlations with PedsQL Parent (r=-0.55; p=0.000), CHAQ (r=0.72; p=0.000) and JADAS total score (r=0.53; p= 0.000). The Turkish version of JAFAR was found to be clinically valid and reliable in JIA.